Sutter Health Joins Cutting-Edge Study for Early Breast Cancer Detection
Under the guidance of Sutter Health Research, several Sutter Health sites across Northern California are participating in a study that is evaluating a new tool for detection of early stage breast cancer.
The multicenter study, called the STRIVE Study, will evaluate a new blood test to be complementary to mammography for early detection of breast cancer. The test is being developed by GRAIL, Inc., and the study is recruiting women at mammography centers across the Sutter Health system and Mayo Clinic.
“The STRIVE Study is unprecedented in its size and scope, and has the potential to improve how we screen for breast cancer in the future,” said Walter “Buzz” Stewart, Ph.D., MPH, Sutter Health’s chief research officer.
The STRIVE Study is one of the largest of its kind for a health system. Sutter Health’s California Pacific Medical Center Research Institute Senior Scientist Steven Cummings, M.D., is the principal investigator of the study.
“Breast cancer is the most common cancer in women, in both developed and less developed countries around the globe,” said Dr. Cummings. “I am delighted to be part of this initiative evaluating how new technology might enhance early detection of breast cancer and other cancers.”
Breast cancer that is found early is easier to treat successfully. Regular mammograms are the current standard of care for breast cancer screening. However, in some women, breast cancer can be difficult to detect with existing screening methods.
During the STRIVE Study, blood samples will be collected from women who consent to participate in the study at the time of their mammogram. Blood samples will be analyzed for small pieces of cell-free tumor-derived nucleic acids. The study will enroll approximately 120,000 women receiving screening mammography at Sutter Health, Mayo Clinic, and other sites. Women will be followed for at least five years after their screening mammogram.
Given its location in Northern California—one of the most diverse populations in the world—Sutter Health Research work with the STRIVE study could help pioneer breakthroughs in early diagnosis that may help improve patients’ experiences throughout the United States and beyond.
According to the American Cancer Society, approximately 232,000 women in the United States are diagnosed with breast cancer annually, and more than 40,000 women die from the disease every year.